BridgeMD
New treatment option for Prolonged Second Stage of Labor
Official title Use of Lubricant Gel to Shorten the Second Stage of Labor During Vaginal Delivery
ClinicalTrials.gov ID: NCT07428317
What this study is testing
- What it's testing
- This experimental study aims to evaluate whether the application of obstetric lubricant gel during vaginal delivery can significantly reduce the duration of the second stage of labor, preserve perineal integrity, and decrease the need for episiotomies. The study hypothesis is that lubricant gel facilitates fetal passage through the birth canal by reducing friction, shortening the expulsion phase and reducing maternal-neonatal complications.
- Which group you join is decided by chance.
A plain-language read of the study's public ClinicalTrials.gov listing. The study team confirms the details.
Who can take part
Ages 18 to 49, women only. Healthy volunteers may be eligible.
You may be able to join if
- Signed informed consent form
- Willingness to comply with study procedures
- Age between 18 and 40 years
- Term pregnancy (37-41.6 weeks) with active labor
- Diagnosis of spontaneous labor and planned vaginal delivery
You likely can't join if
- Multiple pregnancy
- Previous cesarean section
- High-risk pregnancy (preeclampsia, uncontrolled gestational diabetes, etc.)
- Presence of fever or active infection
- Contraindication for vaginal delivery
- Refusal to sign informed consent
See the full eligibility criteria
- Signed informed consent form
- Willingness to comply with study procedures
- Age between 18 and 40 years
- Term pregnancy (37-41.6 weeks) with active labor
- Diagnosis of spontaneous labor and planned vaginal delivery
- Fetus in cephalic presentation
- Agreement to comply with lifestyle restrictions during the study
- Multiple pregnancy
- Previous cesarean section
- High-risk pregnancy (preeclampsia, uncontrolled gestational diabetes, etc.)
- Presence of fever or active infection
- Contraindication for vaginal delivery
- Refusal to sign informed consent
- Premature rupture of membranes \>18 hours without labor
- Known allergy to lubricant gel components
- Participation in another clinical trial in the last 3 months
The study team makes the final eligibility decision.
Where it's taking place
- Tegucigalpa, Francisco Morazán Department, Honduras
Compensation & support
Compensation mentioned.
ClinicalTrials.gov doesn't provide a reliable structured field for payment or travel support - confirm details with the study team.
Questions & answers
Do participants get paid in this trial?
This study's listing includes signals that participants may be compensated or receive a stipend. Amounts vary and are set by the study team - confirm the details with them.
Is it free to join, and do I need insurance?
Searching and applying through BridgeMD is free. In clinical trials the study-related treatment and visits are generally provided at no cost to you. You usually don't need insurance to take part - confirm specifics with the study team.
How long does this study last?
The listing doesn't state an exact length. The study team walks you through the schedule and number of visits before you decide to enroll.
Who can join this trial?
This study is enrolling female, 18 years to 49 years. Healthy volunteers may be eligible. The study team makes the final eligibility decision.
Where is this trial taking place?
Study sites include Tegucigalpa, Francisco Morazán Department, Honduras. Enter your location above to see the nearest site and check your eligibility.
Explore other conditions
BridgeMD is an information and trial-matching tool - not medical advice, and not the study sponsor. Details come from ClinicalTrials.gov; the study team decides eligibility.